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ABSTRACT
GW182 family proteins are essential for miRNA-
mediated gene silencing in animal cells. They are
recruited to miRNA targets via interactions with
Argonaute proteins and then promote translational
repression and degradation of the miRNA targets.
The human and Drosophila melanogaster GW182
proteins share a similar domain organization and
interact with PABPC1 as well as with subunits of the
PAN2-PAN3 and CCR4-NOTdeadenylase complexes.
The homologous proteins in Caenorhabditis elegans,
AIN-1 and AIN-2, lack most of the domains present in
the vertebrate and insect proteins, raising the
question as to how AIN-1 and AIN-2 contribute to
silencing. Here, we show that both AIN-1 and AIN-2
interact with Argonaute proteins through GW
repeats in the middle region of the AIN proteins.
However, only AIN-1 interacts with C. elegans and D.
melanogaster PABPC1, PAN3, NOT1 and NOT2, sug-
gesting that AIN-1 and AIN-2 are functionally distinct.
Ourfindingsrevealasurprisingevolutionaryplasticity
oftheGW182proteininteractionnetworkanddemon-
strate that binding to PABPC1 and deadenylase
complexes has been maintained throughout evolu-
tion,highlightingthesignificanceoftheseinteractions
for silencing.
INTRODUCTION
The proteins AIN-1 and AIN-2 have important and par-
tially redundant functions in the miRNA pathway in
Caenorhabditis elegans (Ce) (1–4). They are highly diver-
gent members of the GW182 protein family, which plays
an essential role in miRNA-mediated gene silencing in
animals (5). In vertebrates and several invertebrate
species, there are up to three GW182 paralogs with
partially redundant functions, whereas there is only one
orthologous protein in Drosophila melanogaster (Dm
GW182).
GW182 family proteins are characterized by an
N-terminal region (N-term) containing multiple glycine–
tryptophan repeats (GW repeats), a central ubiquitin-
associated (UBA) domain and a C-terminal RNA
recognition motif (RRM) (Figure 1A) (2,6–9). Additional
regions of the protein include a glutamine-rich (Q-rich)
region, which is located between the UBA domain and the
RRM,andamiddle(Mid)andC-terminal(C-term)regions
containing few or none GW repeats (Figure 1A) (6–9).
The N-term GW repeat region of the proteins mediates
binding to the Argonaute (AGO) proteins and thus is es-
sential for miRNA-mediated gene silencing (7,10–15). The
Mid and C-term regions (collectively termed the silencing
domain, SD) are also required for silencing (12,13,16,17).
Indeed, GW182 protein mutants lacking the silencing
domain fail to rescue silencing of several miRNA
reporters in cells lacking endogenous GW182, even
though these proteins interact with AGO proteins and
are active in tethering assays (12,17–21).
The precise mechanism by which GW182 proteins
mediate silencing is not completely understood.
However, important insight was provided by the observa-
tion that these proteins interact with the cytoplasmic
poly(A)-binding protein (PABPC1) and with subunits of
the two major cytoplasmic deadenylase complexes (the
PAN2-PAN3 and CCR4-NOT complexes) both in D.
melanogaster and human cells (17,19–25).
Binding to PABPC1 is mediated by a conserved PAM2
motif (PABP-binding motif 2) located in the Mid region.
This motif directly binds to the C-term MLLE domain of
PABPC1 (17,22–24). Moreover, the protein sequences
downstream of the PAM2 motif (termed M2) together
with the C-term region mediate indirect binding to
PABPC1 in vivo (17).
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human GW182 proteins (known as TNRC6A, B and C)
confer direct binding to PAN3 and NOT1, which are
subunits of the PAN2-PAN3 and CCR4-NOT
deadenylase complexes, respectively (20,21,25). Binding
to PAN3 is mediated by the M2- and C-term regions of
the silencing domain (20), whereas NOT1 binding requires
W-containing motifs in the M1, M2 and C-term regions
(Figure 1A) (20,21,25). The interactions with the
deadenylase complex subunits are conserved in Dm
(20,21).
Remarkably, the Ce proteins AIN-1 and AIN-2 show
<12% global sequence identity to Dm GW182 and human
TNRC6s and do not contain sequences homologous to the
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Figure 1. Interaction of AIN-1 and AIN-2 proteins with ALG-1. (A) Domain organization of Dm GW182. The N-term ABD is shown in red, with
GW repeats shown as white vertical bars; Mid, Middle domain with PAM2 motif, M1 and M2 regions; The silencing domain includes the Mid and
C-term regions but not the RRM, which is dispensable for silencing (38). (B) Domain organization of AIN-1 and AIN-2. Regions colored in red and
green show limited similarity to the corresponding regions in Dm GW182. Cc, region with helical propensity. Gray lines underneath AIN-1 schematic
represent protein fragments required for the interaction with the indicated partners. (C–E) S2 cells were cotransfected with plasmids expressing
GFP-tagged Dm GW182, AIN-1 or AIN-2, and HA-tagged Ce ALG-1 or Dm AGO1. Cell lysates were immunoprecipitated using a polyclonal
anti-GFP antibody. GFP-tagged ﬁreﬂy luciferase served as a negative control. For the HA-tagged proteins, inputs (1%) and immunoprecipitates
(35%) were analyzed. For the GFP-tagged proteins, 3.5% of the inputs and 8% of the IPs were loaded. In panel D, cell lysates were treated with
Micrococcal nuclease (MNase).
5652 Nucleic Acids Research, 2012,Vol.40, No. 12silencing domain (Figure 1B) (2,8,9). They also lack UBA
and RRM domains, a PAM2 motif, as well as a deﬁned
Q-rich region. One common feature between AIN-1,
AIN-2 and other GW182 proteins is the presence of GW
repeats, which are dispersed within the N-term and Mid
regions of AIN-1 and AIN-2. Accordingly, AIN-1 and
AIN-2 coimmunoprecipitate Ce AGO-like proteins 1
and 2 (ALG-1 and ALG-2) (1,3). However, it is not
known which GW repeats in AIN-1 and AIN-2 contribute
to ALG-1 and ALG-2 binding.
The highly divergent sequences of AIN-1 and AIN-2
raise the question regarding how these proteins contribute
to silencing and whether there are differences in the mech-
anisms of silencing between species. One possibility is that
AIN-1 and AIN-2 perform similar functions as their ver-
tebrate and insect homologs but have evolved different
modes of interaction with PABPC1 and deadenylase
complexes. Alternatively, AIN-1 and AIN-2 may serve
as adaptor proteins between ALG-1,2 and other
protein(s), which in turn mediate binding to PABPC1
and deadenylase complexes. Finally, miRNA-mediated
gene silencing in Ce may occur by a different mechanism
that does not require interactions with PABPC1 or
deadenylase complexes, although miRNA targets have
also been reported to undergo deadenylation in Ce (26).
In this study, we identiﬁed the GW repeats that are
required for AIN-1 and AIN-2 to interact with ALG-1.
Despite the low sequence conservation with Drosophila
and human GW182 proteins, we found that AIN-1 inter-
acts with Ce PABPC1 (PAB-1), PAN3, NOT1 and NOT2,
whereas AIN-2 showed no signiﬁcant interaction. Thus,
despite strong sequence divergence, the interaction of
AIN-1 with PABPC1 and deadenylase complexes has
been conserved throughout evolution, underscoring their
importance for miRNA-mediated gene silencing.
MATERIALS AND METHODS
Sequence analysis
Ce AIN-1 (WBGene00015547) and AIN-2 (WBGene000
15007) sequences were analyzed using sensitive methods
such as PSI-BLAST and HHpred (27,28). The sequence
identity of the paralogous sequences of AIN-1 and AIN-2
is  12%, but the Mid and C-term regions show some
common features, as depicted in Figure 1A and B.
Sequence homology to the AGO-binding region of Dm
GW182 was detected using extensive PSI-BLAST
searches (red region). Sequence homology for another
region (green) to a region in Dm GW182 (amino acids
721–795) was also detected using HHpred. This region
shows helical propensity and is annotated as Q-rich in
Dm GW182.
Plasmids
Luciferase reporters and plasmids for expression of
miRNAs, Dm AGO1, Dm GW182, Dm PABPC1 and
subunits of the Drosophila deadenylase complexes were
described before (7,19,20,29). The AGO1 F2V2 mutant
carries valine substitutions of phenylalanines 594
(F594V) and 629 (F629V) (11). For expression of Ce
proteins, the corresponding cDNAs were cloned into the
pAc5.1A– N-HA or pAc5.1–EGFP vectors as described
in Supplementary Table S1. Mutations in AIN-1 and
AIN-2 were generated by site-directed mutagenesis using
the QuickChange mutagenesis kit from Stratagene.
Coimmunoprecipitations and western blots
Coimmunoprecipitations were performed as previously
described (17). Brieﬂy, S2 cells were transfected in
six-well plates using the Effectene Transfection Reagent
(Qiagen). The transfection mixtures contained 1, 0.2 and
1mg of plasmid expressing GFP-tagged Dm GW182,
AIN-1 and AIN-2, respectively, or the corresponding
mutants, and 0.5mg of HA-tagged proteins (Ce PABP,
Ce ALG-1, Dm AGO1 or deadenylation factors). Dm
PABPC1 was expressed with a C-term V5 tag. Cells
(10–12 10
6 cells) were harvested 3 days after transfec-
tion, washed with PBS and lysed on ice in 0.5ml of
NET buffer [50 mM Tris (pH 7.4), 150mM NaCl, 1mM
EDTA and 0.1% Triton X-100] containing a protease in-
hibitor cocktail for 30min. Cell lysates were supplemented
with 2.5mM CaCl2 and treated with micrococcal nuclease
for 30min. After removal of insoluble proteins, cell lysates
were incubated with homemade rabbit polyclonal
anti-GFP antibodies (2ml) for 1h. Subsequently, Protein
A-Sepharose beads (GE HealthCare, 50ml) were added
and samples were gently rotated for 1h at 4 C. Beads
were washed 3 times with NET buffer and once with
NET buffer without Triton X-100. Proteins were eluted
with SDS–PAGE sample buffer and analyzed by western
blotting using conventional procedures. Small aliquots
from cell lysates prior and after Micrococcal nuclease
treatment were analyzed by native agarose gel electro-
phoresis to conﬁrm that rRNA was efﬁciently degraded.
HA- and GFP-tagged proteins were detected using
HRP-conjugated monoclonal anti-HA (Roche 3F10;
1:5000) and anti-GFP antibodies (Roche 11 814 460 001;
1:2000), respectively. V5-tagged proteins were detected
with anti-V5 antibodies (Invitrogen, 1:5000). All western
blots were developed with the ECL western blotting
detection system (GE Healthcare) as recommended by
the manufacturer.
Complementation and tethering assays in S2 cells
S2 cells were transfected in 24- or 6-well plates using
Effectene transfection reagent (Qiagen). For the tethering
assay, the following plasmids were cotransfected (amounts
are given for six-well plates): 0.1mg reporter plasmid
(F-Luc-5BoxB or F-Luc without 5BoxB), 0.4mg pAc5.1–
R–Luc as transfection control and various amounts of
plasmids expressing  N-HA-protein fusions (adjusted to
obtain equal expression levels for all proteins tested).
Fireﬂy and Renilla luciferase activities were measured 3
days after transfection using the Dual-Luciferase
Reporter Assay System (Promega).
AGO1 complementation assays were performed as
described before (11). The following siRNAs were used:
AGO1 50-CGAAGGAGAUCAAGGGUUUUU-30 and
b-Gal 50-CUACACAAAUCAGCGAUUUUU-30;D h a r -
macon). GW182 complementation assays were performed
Nucleic Acids Research, 2012,Vol.40, No. 12 5653aspreviouslydescribed(12).FormiRNA-mediatedsilencing
assays, the transfection mixtures contained (amounts given
for24-wellplates):20ngofﬁreﬂyluciferasereporterplasmid,
80ng of the Renilla transfection control and 40ng of
plasmids expressing miRNA primary transcripts or the
corresponding vector without insert. When indicated,
10–100ng of plasmid expressing recombinant protein was
cotransfected.
Fireﬂy and Renilla luciferase activities were measured 4
(AGO1 complementation) or 3 (GW182 complementa-
tion) days after transfection using the Dual-Luciferase
Reporter Assay System (Promega). Total RNA was
isolated using TriFast (Peqlab Biotechnologies) and
analyzed as previously described (12).
RESULTS
AIN-1 and AIN-2 interact with ALG-1 through GW
repeats in the Mid region
Sequence comparison and secondary structure predictions
indicated that AIN-1 and AIN-2 consist of ﬁve different
regions (Figure 1B): an N-term low-complexity region
containing 5 and 1GW repeats, respectively; a region of
homology to the AGO-binding domain (ABD) of human
TNRC6s and Dm GW182, containing additional 2 and
3GW repeats, respectively; a linker region (L) rich in
serine and glycine residues; a region with limited similarity
to the Q-rich region of Dm GW182 (Cc), which exhibits
helical propensity; and a C-terminal tail (Ct). Overall, the
sequence identity between AIN-1 and AIN-2 and
orthologous vertebrate and insect proteins is <12%,
whereas AIN-1 and AIN-2 exhibit 22.4% identity
(Supplementary Table S2).
To analyze the interaction of AIN-1 and AIN-2 with
potential-binding partners, we used a heterologous system
based on Dm S2 cells. We validated this approach by
showing that AIN-1 and AIN-2 interacted with ALG-1
in these cells. Indeed, GFP-tagged versions of AIN-1
and AIN-2 coimmunoprecipitated HA-tagged ALG-1 in
lysates from S2 cells coexpressing these proteins
(Figure 1C and D, lanes 7 and 8). Interestingly, Dm
GW182 also bound to ALG-1 (Figure 1C and D,
lane 6), indicating that the mode of interaction is
conserved. Conversely, both AIN-1 and AIN-2
coimmunoprecipitated Dm AGO1 (Figure 1E), consistent
with the observation that ALG-1 and AGO1 exhibit 61%
identity (Supplementary Table S3). The interactions with
ALG-1 were observed in cell lysates treated with
Micrococcal nuclease, suggesting that they are not
mediated by RNA (Figure 1D, MNase).
To deﬁne the regions in AIN-1 required for ALG-1
binding, we generated mutants lacking either the
N-term, Mid or C-term regions (Figure 1B) and tested
them in coimmunoprecipitation assays. We observed
that deletion of the AIN-1 Mid region abolished ALG-1
binding, whereas deletion of the N-term or C-term regions
had no effect (Figure 2A). Furthermore, protein fragments
containing only the AIN-1 Mid region or the Mid region
without the linker (hereafter termed the AGO-binding
domain, ABD) were sufﬁcient for binding to ALG-1
(Figure 2A, lane 11; Figure 2B, lanes 7 and 8). These
results indicate that the N-term GW repeats do not
signiﬁcantly contribute to the AIN-1/ALG-1 interaction.
The ABD of AIN-1 contains two GW repeats; to
examine their contribution to ALG-1 binding, we
substituted the tryptophan residues in each repeat with
alanines. These substitutions slightly reduced AIN-1
binding to ALG-1 (Figure 2C, lanes 10 and 11). A
stronger reduction was observed when the substitutions
were combined (Figure 2C, lane 12). However, the
AIN-1 double mutant retained some residual ALG-1
binding relative to the AIN-1 mutant lacking the entire
Mid region (Figure 2C, lane 12 versus 9), indicating that
additional residues in the Mid region contribute to the
interaction.
A similar analysis of the interaction of AIN-2 with
ALG-1 revealed that the corresponding ABD is essential
for this interaction (Figure 2D, lane 13). The AIN-2 ABD
contains 3GW repeats. We observed that alanine substi-
tution of the tryptophan residue in the ﬁrst repeat
(GW1-A) reduced binding to ALG-1, whereas substitu-
tions in repeats 2 and 3 had no effect (Figure 2D, lanes
14–16). ALG1 binding was abolished when repeats 1 and 2
were substituted simultaneously (Figure 2D, lane 17),
whereas substitutions in repeats 1 and 3 or 2 and 3
reduced but did not abolish binding (Figure 2D, lanes
18 and 19). We conclude that the GW repeats in the
ABD are essential for AIN-2 to interact with ALG-1.
These repeats contribute to ALG-1 binding in an
additive manner as previously observed for the human
and Dm GW182 proteins (10,12,13,15,30). These results
also indicate that a GW repeat present in the
AIN-2N-term region does not detectably contribute to
the interaction with ALG-1.
AIN-1 interacts with the RRM domains of PAB-1
We next tested whether AIN-1 and AIN-2 interact with Ce
PAB-1. Remarkably, only AIN-1 coimmunoprecipitated
HA-tagged Ce PAB-1 (Figure 3A and B, lane 7). In
contrast, AIN-2 did not detectably interact with PAB-1,
although it was expressed at similar levels (Figure 3A and
B, lane 8). Interestingly, although Ce and Dm PABPC1
exhibit 51.5% identity (Supplementary Table S3), Dm
GW182 did not interact with Ce PAB-1 (Figure 3A and
B, lane 6). In contrast, AIN-1 interacted with Dm
PABPC1 (Figure 3C, lanes 11 and 15). The interaction of
AIN-1 with Ce or Dm PABPC1 was observed in extracts
treated with Micrococcal nuclease, suggesting that this
association is not mediated by RNA (Figure 3B and C).
PABPC1 contains four N-term RRM1–4, a proline-rich
unstructured linker, and a C-term domain [termed PABC
or MLLE because of a conserved KITGMLLE signature
motif in this domain; Figure 3D; (24)]. Human TNRC6
and Dm GW182 interact directly with the C-term MLLE
domain of PABPC1 through a conserved PAM2 motif
located in the Mid region of the silencing domain [see
Figure 1A; (17,22–24)]. However, we could not identify
a PAM2 motif in AIN-1. To map the sequences in
AIN-1 required for PAB-1 binding, we performed
coimmunoprecipitations using the deletion mutants
5654 Nucleic Acids Research, 2012,Vol.40, No. 12described above. We observed that deletion of the N-term
or Mid regions of AIN-1 reduced the interaction with
PAB-1, whereas deletion of the C-term region was incon-
sequential (Figure 3E, lanes 9, 10 and 12). However,
neither the N-term nor the Mid regions in isolation were
sufﬁcient for binding (Figure 3E and F). Thus, both the
N-term and Mid regions contribute to PAB-1 binding
(Figure 1B).
We next investigated whether AIN-1 interacts with the
MLLE domain of PAB-1 despite the lack of a PAM2
motif. We observed that AIN-1 interacted preferentially
with the RRM domains of PAB-1 but not with the MLLE
domain (Figure 3G). We conclude that the interaction of
GW182 proteins with PABP is conserved, although the
interaction mode may differ between species.
AIN-1 interacts with the PAN3 C-term kinase-like
domain
We next studied whether AIN-1 and AIN-2 interact with
Ce PAN3. As observed for PAB-1, only AIN-1 interacted
with Ce PAN3 in an RNA-independent manner
(Figure 4A and B, lane 7), whereas AIN-2 or GW182
did not bind (Figure 4A and B, lanes 6 and 8). In
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efﬁciently than Dm GW182 (Figure 4C and D).
Our previous studies showed that human TNRC6
proteins interact with PAN3 through the M2 and
C-term regions of the silencing domains (20). We
observed that deletion of either the N-term or C-term
regions of AIN-1 reduced binding to PAN3 (Figure 4E
and Supplementary Figure S1A). In contrast, a protein
fragment containing both the N-term and C-term
regions but lacking the Mid region (Mid) interacted
with PAN3 to a similar extent as full-length AIN-1
(Figure 4E, lane 10 and Supplementary Figure S1A),
indicating that the N-term and C-term regions both con-
tribute to the interaction. Accordingly, the isolated
N-term or C-term regions did not interact with PAN3
(Supplementary Figure S1A).
PAN3 proteins contain an N-term region and a C-term
domain with homology to protein kinases (Figure 4F). The
PAN3 N-term region contains a canonical PAM2 motif
andinteractswithPABPC1,whereastheC-termkinase-like
domain is required for PAN3 binding to PAN2, the cata-
lytic subunit of the PAN2–PAN3 deadenylase complex
(31–33). Our previous studies showed a direct interaction
between human TNRC6 proteins and the kinase-like
domain of PAN3 (20). Likewise, AIN-1 interacted with
the PAN3 kinase-like domain but not with the N-term
region (Figure 4G). Thus, the interaction of GW182
proteinswiththekinase-likedomain ofPAN3isconserved.
Since the PAN3 kinase-like domain does not interact with
PABPC1, we conclude that AIN-1 interacts with PAN3
independently of PABPC1, as previously reported for
human TNRC6s (20).
AIN-1 interacts with NOT1 and NOT2
Wealso examinedtheinteractionof AIN-1 andAIN-2 with
NOT1 and NOT2, which are the subunits of the
CCR4-NOT complex that exhibit the strongest interaction
with Dm GW182 (20). We observed that AIN-1 interacted
withCeNOT1andCeNOT2(a.k.a.NTL-2)(Figure5A–C,
lane7),aswellaswithDmNOT1andDmNOT2(Figure5D
and E), whereas AIN-2 showed very weak binding to Ce
NOT1 (Figure 5B, lane 8). Immunoprecipitations with
AIN-1 deletion mutants, revealed that full-length AIN-1 is
required for binding to NOT1, as deletion of either the
N-term, Mid or C-term regions reduced binding and none
of these regions in isolation was sufﬁcient for binding
(Figure 5F). In contrast, the AIN-1 interaction with
NOT2 is mediated by the N-term and C-term regions, as
an AIN-1 mutant lacking the Mid domain coimmunopre-
cipitated NOT2 to a similar extent as the full-length protein
(Figure 5G, lane 14 versus 10; see Figure 1B).
Recent work showed that the interaction of human
TNRC6s with NOT1 is mediated by W-containing
motifs in the M1, M2 and C-term regions of the silencing
domains (21,25). These motifs contribute to the afﬁnity of
the interaction in an additive manner. AIN-1 contains a
total of 22 tryptophan residues (of which 7 are in GW
repeats) in the N-term and Mid regions, whereas the
C-term region lacks tryptophan residues. To investigate
the potential contribution of W-containing motifs to
deadenylase binding, we generated an AIN-1 mutant in
which all tryptophan residues were substituted with
alanines (AIN-1-22 W-A). This mutant displayed lower
mobility in SDS–PAGE and no longer interacted with
NOT1 and NOT2 (Supplementary Figure S1B and S1C).
As expected, the substitutions abrogated AGO1 and
ALG-1 binding (Supplementary Figure S1D and S1E).
Unexpectedly, interaction with PAB-1 and PAN3 was
also abolished (Supplementary Figure S1F and S1G), sug-
gesting that simultaneous substitution of 22 tryptophan
residues by alanines non-speciﬁcally disrupted protein–
protein interactions. Nevertheless, our data do not rule
out that a subset of tryptophan residues is involved in
mediating NOT1 binding, as shown recently (21, 25).
ALG-1 rescues silencing in cells depleted of AGO1
Given that the interactions of GW182 proteins with AGOs
are conserved and that Dm GW182 interacts with Ce
ALG-1, we tested if ALG-1 could rescue silencing in S2
cells depleted of AGO1, which is the AGO protein
dedicated to the miRNA pathway in D. melanogaster
(34). To this end, we made use of a complementation
assay as previously described (11). In this assay, S2 cells
were transfected with either siRNA speciﬁc to AGO1 or a
control siRNA against b-Gal. We then tested ALG-1 for
its ability to restore silencing in AGO1-depleted cells.
We monitored miRNA activity using previously
characterized ﬁreﬂy luciferase reporters, including the
F-Luc-Par-6 reporter (silenced by miR-1) and the
F-Luc-Nerﬁn-1 reporter [silenced by miR-9b; (7,29)].
Depletion of endogenous AGO1 suppressed silencing of
the reporters, leading to a 6- to 7-fold increase in ﬁreﬂy
luciferase expression (Figure 6A–D). Transfecting AGO1-
depleted cells with a plasmid expressing a siRNA-resistant
form of AGO1 fully restored silencing (Figure 6A–D) as
reported previously (11). Interestingly, ALG-1 also
restored silencing in AGO1-depleted cells (Figure 6A–D)
when expressed at similar levels (Figure 6E). In contrast,
neither ALG-1 nor AGO1 rescued silencing in cells in
which AGO1 and Dm GW182 were codepleted
(Figure 6F and G), indicating that both AGO1 and
ALG-1 interact with Dm GW182 to silence miRNA
targets. Accordingly, coexpression of AGO1 or ALG-1
with a dsRNA-resistant form of Dm GW182 rescued
silencing in cells codepleted of AGO1 and GW182
(Figure 6F and G). These results indicate conservation
in the mechanisms of miRNA loading and target silencing.
AIN-1 and AIN-2 repress expression of bound mRNAs
To investigate the conservation of the pathway down-
stream of AGOs, we tested whether AIN-1 and AIN-2
could repress expression of target mRNAs using a
tethering assay as previously described (35). AIN-1 and
AIN-2 were expressed with two tags: a peptide derived
from the bacteriophage   N protein ( N tag) to enable
tethering to a ﬁreﬂy luciferase (F-Luc) reporter and an
HA tag (hemagglutinin) to allow detection of the
expressed protein by western blot. The F-Luc reporter
contains ﬁve Box B hairpins (5BoxB) inserted in the
30-UTR; these bind the  N tag with high afﬁnity and
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Figure 5. AIN-1 interacts with NOT1 and NOT2. (A–E) Interaction of GFP-tagged GW182, AIN-1 or AIN-2 with HA-tagged NOT1 or NOT2. For
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A plasmid encoding Renilla luciferase served as a trans-
fection control (R-Luc).
We observed that both AIN-1 and AIN-2 repressed
expression of the F-Luc-5BoxB reporter relative to the
 N-HA tag or a negative mutant of Dm AGO1 termed
F2V2 [Figure 7A–C; (11)]. The repression was similar to
that observed with Dm GW182, which served as the
positive control (Figure 7A–C). Furthermore, the repres-
sion was speciﬁc; the expression of an F-Luc reporter
lacking the BoxB hairpins was unaffected by Dm
GW182, AIN-1 or AIN-2 expression (Supplementary
Figure S2A–C). Importantly, AIN-1 and AIN-2 silenced
the F-Luc-5BoxB reporter in AGO1-depleted cells,
indicating that their activity in tethering assays is not
mediated by AGO1 (Supplementary Figure S2D and E).
These results are not due to inefﬁcient depletion because
silencing of the F-Luc-Par-6 reporter by miR-1 was
completely suppressed in these cells (Supplementary
Figure S2E). To conﬁrm that AIN-1 and AIN-2 activities
are independent of AGO proteins, we tested protein
mutants that do not interact with ALG1 (i.e. carrying de-
letions of the Mid domain or mutations in the GW repeats
of the ABD). All mutants repressed the F-Luc-5BoxB
reporter similar to the wild-type protein (Figure 7D and
Supplementary Figure S2F), but did not affect the
expression of a reporter lacking the BoxB hairpins
(Supplementary Figure S2G–S2I). In contrast, the
AIN-1 mutant with 22 tryptophan-to-alanine substitu-
tions was inactive in this assay (Figure 7D, 22 W-A).
Northern blot analysis of the F-Luc-5BoxB mRNA
revealedthatbothAIN-1andAIN-2reducedtheabundance
of the F-Luc-5BoxB mRNA by  2.5-fold relative to the
R-Luc mRNA transfection control (Figure 7A and B).
Remarkably, all of the tested AIN-1 or AIN-2 protein
fragments that were active in the tethering assays
promoted mRNA degradation (Figure 7D and E).
However, the decrease in mRNA levels was smaller than
the reduction observed in ﬁreﬂy luciferase activity, suggest-
ing a net contribution of translational repression. Similarly,
previous studies showed that almost all fragments of Dm
GW182promotedtranslationalrepressionandmRNAdeg-
radation in tethering assays, including N-term fragments
that do not interact with PABPC1 (18,21,36). Therefore,
we conclude that the activity of the GW182 protein frag-
ments in tethering assays is not correlated with AGO,
deadenylaseorPABPC1binding incoimmunoprecipitation
assays.However,wecannotruleoutthattransientandweak
interactions occur in vivo that are not detectable under the
conditions used for coimmunoprecipitations.
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primary transcripts or the corresponding empty vector ( ); and a third
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5660 Nucleic Acids Research, 2012,Vol.40, No. 12AIN-1 and AIN-2 do not rescue silencing in cells depleted
of GW182
As mentioned above, previous reports documented that
multiple and non-overlapping fragments of Dm GW182
are active in tethering assays including N-term fragments
(18,21,36). However, despite their activity in tethering
assays, GW182 N-term protein fragments did not rescue
silencing in cells lacking endogenous GW182 in comple-
mentation assays (except for the Nerﬁn reporter silenced
by miR-9b), but rather inhibited silencing in a
dominant-negative manner (12,18). Therefore, we next
tested the silencing activity of AIN-1 and AIN-2 in com-
plementation assays.
Knockdown of endogenous Dm GW182 in S2 cells was
achieved using dsRNA targeting GW182 mRNA. This
depletion inhibited silencing of the reporters tested,
leading to a 2.5- to 3-fold increase in ﬁreﬂy luciferase ex-
pression (Figure 8A–D). GW182-depleted cells were then
transfected with a plasmid expressing a dsRNA-resistant
version of GW182, which restored silencing (Figure 8A–D)
as previously reported (12). Despite similar expression
levels, neither AIN-1 nor AIN-2 restored silencing in
GW182-depleted cells (Figure 8A–E and Supplementary
Figure S3A–S3D). Moreover, coexpression of AIN-1 and
AIN-2 also failed to rescue silencing (Figure 8A–D).
Likewise, coexpression of AIN-1 with Ce ALG-1, PAN3,
NOT1 or PAB-1 did not rescue silencing (Supplementary
Figure S3A–S3D). Additionally, both AIN-1 and AIN-2
inhibited silencing in a dominant-negative manner in
control cells (Supplementary Figure S4A and S4B). This
dominant-negative effect was reduced when AIN-1 and
AIN-2 mutants that do not interact with ALG-1 were
tested (Supplementary Figure S4A), suggesting that
AIN-1 and AIN-2 inhibit silencing at least in part by
competing with GW182 for AGO1 binding.
Finally, coexpression of AIN-1 and ALG-1 did not
rescue silencing in S2 cells codepleted of Dm GW182 and
AGO1, whereas coexpression of Dm GW182 with ALG-1
did (Figure 6F and G). Thus, although AIN-1 and AIN-2
were active in tethering assays (Figure 7), both proteins
were inactive in complementation assays (Figure 8).
Together, our results indicate that AIN-1 and AIN-2
are probably too divergent to rescue silencing in
GW182-depleted cells despite that AIN-1 interacts with
Dm AGO1, PABPC1, NOT1, NOT2 and PAN3.
DISCUSSION
GW182 proteins play a central role in the miRNA
pathway in animal cells. Vertebrate and insect members
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Nucleic Acids Research, 2012,Vol.40, No. 12 5661of the family interact with the AGO proteins, PABPC1
and subunits of the two cytoplasmic deadenylase
complexes (the PAN2-PAN3 and the CCR4-NOT
complexes) (5,20,21,25). Despite strong sequence diver-
gence, we demonstrated that Ce AIN-1 interacts with Ce
or Dm PABPC1, PAN3, NOT1 and NOT2, whereas
AIN-2 shows no signiﬁcant interactions. In contrast,
both AIN-1 and AIN-2 interact with ALG-1, as previ-
ously reported (1,3). Our ﬁndings suggest that AIN-1
and AIN-2 are functionally distinct and may silence
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5662 Nucleic Acids Research, 2012,Vol.40, No. 12miRNA targets using different mechanisms. Indeed,
AIN-2 may not promote miRNA target deadenylation
and subsequent degradation, potentially explaining why
AIN-2 depletion has no overt phenotype but enhances
the delayed heterochronic phenotype observed in worms
lacking AIN-1 (2,3). This phenotype includes defects in
alae formation, drastic increase in seam-cell numbers
and protruding vulva (2,3). Alternatively, AIN-2 may be
expressed at lower levels and/or regulate fewer targets.
Finally, AIN-2 may use a similar mechanism but may
recruit PABPC1 and deadenylases through transient
low-afﬁnity interactions or through an adaptor protein(s).
Evolutionary plasticity of the GW182 protein interaction
network
The ﬁnding that AIN-1 interacts with PABPC1, PAN3,
NOT1 and NOT2 is surprising given that AIN-1 shows
<12% sequence identity with Dm GW182 or human
TNRC6s, whereas the binding partners (e.g. PABPC1,
PAN3, NOT1 and NOT2) are conserved (Supplementary
Tables S2 and S3). However, although the interactions of
GW182 proteins with PABPC1, NOT1 and PAN3 are
conserved in humans and D. melanogaster, the mode of
interaction is not. For example, human TNRC6s interact
with PABPC1 through a PAM2 motif in the silencing
domain (17,22–24). This motif is also present in Dm
GW182 and interacts with PABPC1 in vitro; nevertheless,
deletion of the Dm GW182 PAM2 motif does not
abrogate PABPC1 binding in vivo (17). In our previous
studies, we showed that Dm GW182 interacts with
PABPC1 through additional regions in the silencing
domain. Although indirect, this interaction is dominant
over that mediated by the PAM2 motif in vivo (17,19).
Another example of change in the binding mode is the
interaction of GW182 proteins with NOT1. Indeed, recent
work showed that binding of human TNRC6s to NOT1 is
mediated by short motifs in the M1, M2 and C-term
regions of the silencing domains, which contribute to the
interaction in an additive manner (20,21,25). The motif in
the M1 region (termed CCR4-interacting motif 1, CIM-1)
is conserved in Dm GW182 (25). However, in contrast to
human TNRC6s, the silencing domain of Dm GW182 is
not sufﬁcient for binding to NOT1 (our unpublished
results), suggesting that additional motifs upstream of
the silencing domain are present in Dm GW182.
Finally, although the interaction of GW182 proteins
with AGOs is mediated by GW repeats (i.e. GW, WG
or GWG), the exact location and number of repeats is
not conserved (10,12,13,15,30). Here, we show that only
a few repeats in the Mid region of AIN-1 and AIN-2 con-
tribute to their interaction with ALG-1; in contrast, 12
and >20GW repeats in the N-term regions of Dm
GW182 and human TNRC6s, respectively, contribute to
AGO protein binding (12,13).
How can the GW182 protein interaction network be
conserved while the location of the binding sites appears
to be rapidly evolving? The regions of GW182 proteins
mediating the interactions with AGO1, PABPC1 and
deadenylase subunits are predicted to be unstructured.
These unstructured regions interact with (predicted or
known) globular domains in AGO1, PABPC1, PAN3,
NOT1 and NOT2, suggesting that the interactions might
be mediated by short linear motifs [SLiMs; (37)] in the
GW182 unstructured regions. This provides one explan-
ation for why the location of the binding sites is rapidly
evolving. Linear motifs are evolutionarily plastic, as only a
small number of point mutations in a disordered region of
a protein sequence are required to relocate these motifs. In
doing so, the interactions between GW182 and binding
partners can be maintained, but the details can change
during evolution. Additionally, the possibility that
GW182 proteins interact with their partners via SLiMs,
potentially explains why the binding of AIN-1 to
PABPC1, PAN3, NOT1 and NOT2 requires multiple
protein regions (Figure 1B), as SLiMs may be dispersed
along the protein sequence and collectively contribute to
high-afﬁnity interactions. In this context, we can envision
a scenario in which nematode AIN-1 proteins gained add-
itional motifs to interact with PABP and deadenylases, so
that the silencing domain became progressively redundant
and was eventually lost.
Conservation of silencing mechanisms
The present work shows that ALG-1 can rescue silencing
in Drosophila cells depleted of AGO1, demonstrating con-
servation in the miRNA pathway including the mechan-
ism of AGO loading, target recognition and target
silencing. However, despite conservation of the basic
interactions, AIN-1 could not rescue silencing in cells
depleted of Dm GW182. Furthermore, both AIN-1 and
AIN-2 inhibited silencing in a dominant-negative manner
in wild-type cells. This effect was at least in part mediated
by the ABD, suggesting that these proteins compete with
GW182 for binding to AGO1 but assemble non-functional
miRISC complexes. Why are these complexes non-
functional? One possibility is that the assembly of func-
tional silencing complexes requires GW182 proteins to
interact with unknown partners (other than PABPC1
and deadenylase complexes), and that these interactions
are not conserved. Alternatively, changes in protein con-
formation may be required to activate silencing complexes
but may not occur for complexes assembled with AIN-1 or
AIN-2 proteins in S2 cells.
An important message from our study is that AIN-1
and AIN-2 do not complement the Dm GW182 depletion,
although both proteins silence an mRNA reporter to
which they are artiﬁcially tethered. Furthermore, there is
no correlation between activity in tethering assays and
binding to AGO, deadenylases or PABPC1. Similarly,
non-overlapping fragments of Dm GW182, including
N-term fragments that do not interact with PABPC1,
have been shown to be active in tethering assays
(18,21,36). These results were interpreted as evidence
that interactions of GW182 proteins with PABPC1 are
not required for silencing (36). However, in complemen-
tation assays, TNRC6 mutants that do not interact with
PABPC1 (i.e. PAM2 mutants) are impaired in silencing
both in human and S2 cells, indicating that the PABPC1
interaction is critical for silencing in vivo (17,20). One
possible explanation for the discrepancies between
Nucleic Acids Research, 2012,Vol.40, No. 12 5663tethering assays and complementation assays is that
tethering assays involve direct high-afﬁnity binding of
multiple GW182 proteins to the mRNA target and thus
bypass upstream steps in the silencing pathway. Therefore,
although tethering assays are an invaluable tool in the
dissection of the role of GW182 protein domains in
silencing, conclusions from these assays should be
validated in complementation assays.
In summary, our work extends and conﬁrms the evolu-
tionary conservation of GW182 interactions with
PABPC1 and deadenylase complexes, unveiling their im-
portance for silencing. Further elucidating the molecular
basis for these interactions will be key to understanding
their roles in both miRNA-mediated translational repres-
sion and mRNA target degradation.
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